Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 61

1.

Notch signaling and inherited disease syndromes.

Gridley T.

Hum Mol Genet. 2003 Apr 1;12 Spec No 1:R9-13. Review.

PMID:
12668592
2.

Diverse requirements for Notch signalling in mammals.

Sparrow DB, Clements M, Withington SL, Scott AN, Novotny J, Sillence D, Kusumi K, Beddington RS, Dunwoodie SL.

Int J Dev Biol. 2002;46(4):365-74.

3.

Notch signaling in development and disease.

Harper JA, Yuan JS, Tan JB, Visan I, Guidos CJ.

Clin Genet. 2003 Dec;64(6):461-72. Review.

PMID:
14986825
4.

Notch signaling in the developing cardiovascular system.

Niessen K, Karsan A.

Am J Physiol Cell Physiol. 2007 Jul;293(1):C1-11. Epub 2007 Mar 21. Review.

5.

Vascular expression of Notch pathway receptors and ligands is restricted to arterial vessels.

Villa N, Walker L, Lindsell CE, Gasson J, Iruela-Arispe ML, Weinmaster G.

Mech Dev. 2001 Oct;108(1-2):161-4.

6.

Notch signaling in human development and disease.

Penton AL, Leonard LD, Spinner NB.

Semin Cell Dev Biol. 2012 Jun;23(4):450-7. doi: 10.1016/j.semcdb.2012.01.010. Epub 2012 Jan 28. Review.

7.

Mutation of the LUNATIC FRINGE gene in humans causes spondylocostal dysostosis with a severe vertebral phenotype.

Sparrow DB, Chapman G, Wouters MA, Whittock NV, Ellard S, Fatkin D, Turnpenny PD, Kusumi K, Sillence D, Dunwoodie SL.

Am J Hum Genet. 2006 Jan;78(1):28-37. Epub 2005 Nov 16.

8.

Hey genes in cardiovascular development.

Fischer A, Gessler M.

Trends Cardiovasc Med. 2003 Aug;13(6):221-6. Review.

PMID:
12922017
9.

Regulation of vascular morphogenesis by Notch signaling.

Roca C, Adams RH.

Genes Dev. 2007 Oct 15;21(20):2511-24. Review.

10.

Mutation of Hairy-and-Enhancer-of-Split-7 in humans causes spondylocostal dysostosis.

Sparrow DB, Guillén-Navarro E, Fatkin D, Dunwoodie SL.

Hum Mol Genet. 2008 Dec 1;17(23):3761-6. doi: 10.1093/hmg/ddn272. Epub 2008 Sep 5.

PMID:
18775957
11.

When body segmentation goes wrong.

Pourquié O, Kusumi K.

Clin Genet. 2001 Dec;60(6):409-16. Review.

PMID:
11846732
12.

CADASIL and genetics of cerebral ischaemia.

Kalaria RN, Low WC, Oakley AE, Slade JY, Ince PG, Morris CM, Mizuno T.

J Neural Transm Suppl. 2002;(63):75-90. Review.

PMID:
12597610
13.

Notch and vascular smooth muscle cell phenotype.

Morrow D, Guha S, Sweeney C, Birney Y, Walshe T, O'Brien C, Walls D, Redmond EM, Cahill PA.

Circ Res. 2008 Dec 5;103(12):1370-82. doi: 10.1161/CIRCRESAHA.108.187534. Review.

14.

Notch signaling from tumor cells: a new mechanism of angiogenesis.

Li JL, Harris AL.

Cancer Cell. 2005 Jul;8(1):1-3. Review.

15.

Abnormal vertebral segmentation and the notch signaling pathway in man.

Turnpenny PD, Alman B, Cornier AS, Giampietro PF, Offiah A, Tassy O, Pourquié O, Kusumi K, Dunwoodie S.

Dev Dyn. 2007 Jun;236(6):1456-74. Review.

16.

[Japanese CADASIL case with limited dementia who had the Notch 3 R141C mutation].

Ishibashi K, Murata T, Miki Y, Hara M, Mori H.

No To Shinkei. 2005 May;57(5):415-8. Japanese.

PMID:
15981641
17.

Alagille syndrome and the notch signaling pathway: new insights into human development.

Spinner NB.

Gastroenterology. 1999 May;116(5):1257-60. No abstract available.

PMID:
10220521
18.
19.

NUMB is a break of WNT-Notch signaling cycle.

Katoh M, Katoh M.

Int J Mol Med. 2006 Sep;18(3):517-21.

PMID:
16865239

Supplemental Content

Support Center